thermo fisher scientific blade vii limited
thermo fisher scientific blade vii limited Company Information
Company Number
07579841
Next Accounts
Sep 2025
Shareholders
thermo fisher scientific blade vi limited
Group Structure
View All
Industry
Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
+1Registered Address
3rd floor 1 ashley road, altrincham, cheshire, WA14 2DT
Website
http://bindingsite.co.ukthermo fisher scientific blade vii limited Estimated Valuation
Pomanda estimates the enterprise value of THERMO FISHER SCIENTIFIC BLADE VII LIMITED at £3m based on a Turnover of £3.4m and 0.88x industry multiple (adjusted for size and gross margin).
thermo fisher scientific blade vii limited Estimated Valuation
Pomanda estimates the enterprise value of THERMO FISHER SCIENTIFIC BLADE VII LIMITED at £12.2m based on an EBITDA of £2.8m and a 4.38x industry multiple (adjusted for size and gross margin).
thermo fisher scientific blade vii limited Estimated Valuation
Pomanda estimates the enterprise value of THERMO FISHER SCIENTIFIC BLADE VII LIMITED at £278.6m based on Net Assets of £161.6m and 1.72x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Thermo Fisher Scientific Blade Vii Limited Overview
Thermo Fisher Scientific Blade Vii Limited is a live company located in cheshire, WA14 2DT with a Companies House number of 07579841. It operates in the activities of other holding companies n.e.c. sector, SIC Code 64209. Founded in March 2011, it's largest shareholder is thermo fisher scientific blade vi limited with a 100% stake. Thermo Fisher Scientific Blade Vii Limited is a established, small sized company, Pomanda has estimated its turnover at £3.4m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Thermo Fisher Scientific Blade Vii Limited Health Check
Pomanda's financial health check has awarded Thermo Fisher Scientific Blade Vii Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 4 areas for improvement. Company Health Check FAQs
2 Strong
3 Regular
4 Weak
Size
annual sales of £3.4m, make it smaller than the average company (£19.7m)
£3.4m - Thermo Fisher Scientific Blade Vii Limited
£19.7m - Industry AVG
Growth
3 year (CAGR) sales growth of 6%, show it is growing at a slower rate (9%)
6% - Thermo Fisher Scientific Blade Vii Limited
9% - Industry AVG
Production
with a gross margin of 35%, this company has a comparable cost of product (35%)
35% - Thermo Fisher Scientific Blade Vii Limited
35% - Industry AVG
Profitability
an operating margin of 82.7% make it more profitable than the average company (5.2%)
82.7% - Thermo Fisher Scientific Blade Vii Limited
5.2% - Industry AVG
Employees
with 17 employees, this is below the industry average (108)
- Thermo Fisher Scientific Blade Vii Limited
108 - Industry AVG
Pay Structure
on an average salary of £47.2k, the company has an equivalent pay structure (£47.2k)
- Thermo Fisher Scientific Blade Vii Limited
£47.2k - Industry AVG
Efficiency
resulting in sales per employee of £198.3k, this is equally as efficient (£198.7k)
- Thermo Fisher Scientific Blade Vii Limited
£198.7k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Thermo Fisher Scientific Blade Vii Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Thermo Fisher Scientific Blade Vii Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Thermo Fisher Scientific Blade Vii Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (14 weeks)
0 weeks - Thermo Fisher Scientific Blade Vii Limited
14 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 11.9%, this is a lower level of debt than the average (62.6%)
11.9% - Thermo Fisher Scientific Blade Vii Limited
62.6% - Industry AVG
THERMO FISHER SCIENTIFIC BLADE VII LIMITED financials
Thermo Fisher Scientific Blade Vii Limited's latest turnover from December 2023 is £3.4 million and the company has net assets of £161.6 million. According to their latest financial statements, we estimate that Thermo Fisher Scientific Blade Vii Limited has 17 employees and maintains cash reserves of £29 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 3,371,000 | 2,857,000 | 2,857,000 | 2,857,000 | 2,857,000 | 3,660,000 | 3,625,000 | 1,225,000 | 0 | 0 | 0 | 0 |
| Other Income Or Grants | ||||||||||||
| Cost Of Sales | ||||||||||||
| Gross Profit | ||||||||||||
| Admin Expenses | ||||||||||||
| Operating Profit | 2,788,000 | 2,247,000 | 2,235,000 | 2,216,000 | 2,188,000 | 147,126,000 | 30,095,000 | -9,369,000 | -3,094,000 | -3,000 | 1,176,000 | 305,000 |
| Interest Payable | 244,000 | 195,000 | 197,000 | 173,000 | 173,000 | 16,548,000 | 16,453,000 | 15,378,000 | 14,653,000 | 13,871,000 | 14,343,000 | 19,671,000 |
| Interest Receivable | 0 | 0 | 1,000 | 0 | 0 | 5,000 | 46,000 | 150,000 | 61,000 | 61,000 | 78,000 | 133,000 |
| Pre-Tax Profit | 2,544,000 | 2,052,000 | 2,039,000 | 2,043,000 | 2,015,000 | 164,592,000 | 14,370,000 | -5,221,000 | -17,746,000 | -13,813,000 | -13,089,000 | -19,233,000 |
| Tax | -18,000 | 106,000 | -774,000 | -413,000 | -786,000 | 47,000 | -989,000 | -611,000 | -12,000 | 0 | 0 | 0 |
| Profit After Tax | 2,526,000 | 2,158,000 | 1,265,000 | 1,630,000 | 1,229,000 | 164,639,000 | 13,381,000 | -5,832,000 | -17,758,000 | -13,813,000 | -13,089,000 | -19,233,000 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | 2,526,000 | 2,158,000 | 1,265,000 | 1,630,000 | 1,229,000 | 164,639,000 | 13,381,000 | -5,832,000 | -17,758,000 | -13,813,000 | -13,089,000 | -19,233,000 |
| Employee Costs | 0 | 394,000 | 1,131,000 | 1,544,000 | 1,045,000 | 1,003,000 | 956,000 | 1,001,000 | ||||
| Number Of Employees | 1 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
| EBITDA* | 2,798,000 | 2,851,000 | 2,839,000 | 2,844,000 | 2,818,000 | 147,757,000 | 30,730,000 | -9,369,000 | -3,094,000 | -3,000 | 1,176,000 | 305,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 167,878,000 | 141,073,000 | 141,677,000 | 142,281,000 | 143,110,000 | 144,569,000 | 145,200,000 | 146,376,000 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 151,739,000 | 141,073,000 | 141,677,000 | 142,281,000 | 142,909,000 | 143,539,000 | 144,170,000 | 144,805,000 | 124,179,000 | 124,179,000 | 124,179,000 | 124,720,000 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 201,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 167,878,000 | 141,073,000 | 141,677,000 | 142,281,000 | 143,110,000 | 144,569,000 | 145,200,000 | 146,376,000 | 124,179,000 | 124,179,000 | 124,179,000 | 124,720,000 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 0 | 0 | 0 | 5,000 | 0 | 24,000 | 0 | 0 | 0 | 0 |
| Group Debtors | 0 | 11,764,000 | 8,907,000 | 5,961,000 | 3,106,000 | 281,000 | 1,099,000 | 14,193,000 | 13,225,000 | 13,185,000 | 13,038,000 | 19,905,000 |
| Misc Debtors | 15,461,000 | 49,000 | 49,000 | 43,000 | 43,000 | 0 | 0 | 109,000 | 0 | 41,000 | 23,000 | 20,000 |
| Cash | 29,000 | 117,000 | 105,000 | 100,000 | 101,000 | 360,000 | 2,688,000 | 703,000 | 639,000 | 1,000 | 34,000 | 23,000 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 144,000 | 381,000 | 306,000 | 22,000 | 0 | 0 | 0 |
| total current assets | 15,490,000 | 11,930,000 | 9,061,000 | 6,203,000 | 3,351,000 | 790,000 | 4,168,000 | 15,335,000 | 13,886,000 | 13,227,000 | 13,095,000 | 19,948,000 |
| total assets | 183,368,000 | 153,003,000 | 150,738,000 | 148,484,000 | 146,461,000 | 145,359,000 | 149,368,000 | 161,711,000 | 138,065,000 | 137,406,000 | 137,274,000 | 144,668,000 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 5,552,000 | 8,332,000 | 0 | 4,225,000 | 2,404,000 | 2,439,000 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5,130,000 | 0 | 0 | 0 |
| Trade Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 26,138,000 | 16,913,000 | 9,991,000 | 7,078,000 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 17,184,000 | 1,669,000 | 1,456,000 | 1,241,000 | 1,057,000 | 1,141,000 | 6,000,000 | 36,126,000 | 512,000 | 345,000 | 414,000 | 338,000 |
| total current liabilities | 17,184,000 | 1,669,000 | 1,456,000 | 1,241,000 | 1,057,000 | 1,141,000 | 11,552,000 | 44,458,000 | 31,780,000 | 21,483,000 | 12,809,000 | 9,855,000 |
| loans | 2,500,000 | 17,596,000 | 17,596,000 | 17,596,000 | 17,596,000 | 17,596,000 | 224,166,000 | 224,082,000 | 153,185,000 | 145,046,000 | 139,775,000 | 137,034,000 |
| hp & lease commitments | 1,250,000 | 1,250,000 | 1,250,000 | 1,250,000 | 1,250,000 | 1,250,000 | 1,250,000 | 1,250,000 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 6,592,000 | 6,872,000 | 7,084,000 | 5,536,000 | 5,118,000 | 5,204,000 | 5,298,000 | 4,400,000 | 18,000 | 0 | 0 | 0 |
| total long term liabilities | 4,546,000 | 19,782,000 | 19,888,000 | 19,114,000 | 18,905,000 | 18,948,000 | 177,185,000 | 170,003,000 | 153,203,000 | 145,046,000 | 139,775,000 | 137,034,000 |
| total liabilities | 21,730,000 | 21,451,000 | 21,344,000 | 20,355,000 | 19,962,000 | 20,089,000 | 188,737,000 | 214,461,000 | 184,983,000 | 166,529,000 | 152,584,000 | 146,889,000 |
| net assets | 161,638,000 | 131,552,000 | 129,394,000 | 128,129,000 | 126,499,000 | 125,270,000 | -39,369,000 | -52,750,000 | -46,918,000 | -29,123,000 | -15,310,000 | -2,221,000 |
| total shareholders funds | 161,638,000 | 131,552,000 | 129,394,000 | 128,129,000 | 126,499,000 | 125,270,000 | -39,369,000 | -52,750,000 | -46,918,000 | -29,123,000 | -15,310,000 | -2,221,000 |
| Dec 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||
| Operating Profit | 2,788,000 | 2,247,000 | 2,235,000 | 2,216,000 | 2,188,000 | 147,126,000 | 30,095,000 | -9,369,000 | -3,094,000 | -3,000 | 1,176,000 | 305,000 |
| Depreciation | 10,000 | 604,000 | 604,000 | 628,000 | 630,000 | 631,000 | 635,000 | 0 | 0 | 0 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | -18,000 | 106,000 | -774,000 | -413,000 | -786,000 | 47,000 | -989,000 | -611,000 | -12,000 | 0 | 0 | 0 |
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 3,648,000 | 2,857,000 | 2,952,000 | 2,654,000 | 3,064,000 | -813,000 | -13,227,000 | 1,101,000 | -1,000 | 165,000 | -6,864,000 | 19,925,000 |
| Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 15,515,000 | 213,000 | 215,000 | 184,000 | -84,000 | -4,859,000 | -30,126,000 | 35,614,000 | 167,000 | -69,000 | 76,000 | 338,000 |
| Deferred Taxes & Provisions | -280,000 | -212,000 | 1,548,000 | 418,000 | -86,000 | -94,000 | 898,000 | 4,382,000 | 18,000 | 0 | 0 | 0 |
| Cash flow from operations | 14,367,000 | 101,000 | 876,000 | 379,000 | -1,202,000 | 143,664,000 | 13,740,000 | 28,915,000 | -2,920,000 | -237,000 | 8,116,000 | -19,282,000 |
| Investing Activities | ||||||||||||
| capital expenditure | ||||||||||||
| Change in Investments | 10,666,000 | -604,000 | -604,000 | -628,000 | -630,000 | -631,000 | -635,000 | 20,626,000 | 0 | 0 | -541,000 | 124,720,000 |
| cash flow from investments | ||||||||||||
| Financing Activities | ||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5,130,000 | 5,130,000 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -26,138,000 | 9,225,000 | 6,922,000 | 2,913,000 | 7,078,000 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | -15,096,000 | 0 | 0 | 0 | 0 | -206,570,000 | 84,000 | 70,897,000 | 8,139,000 | 5,271,000 | 2,741,000 | 137,034,000 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,250,000 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||
| interest | -244,000 | -195,000 | -196,000 | -173,000 | -173,000 | -16,543,000 | -16,407,000 | -15,228,000 | -14,592,000 | -13,810,000 | -14,265,000 | -19,538,000 |
| cash flow from financing | 12,220,000 | -195,000 | -196,000 | -173,000 | -173,000 | -223,113,000 | -16,323,000 | 25,651,000 | 7,865,000 | -1,617,000 | -8,611,000 | 141,586,000 |
| cash and cash equivalents | ||||||||||||
| cash | -88,000 | 12,000 | 5,000 | -1,000 | -259,000 | -2,328,000 | 1,985,000 | 64,000 | 638,000 | -33,000 | 11,000 | 23,000 |
| overdraft | 0 | 0 | 0 | 0 | 0 | -5,552,000 | -2,780,000 | 8,332,000 | -4,225,000 | 1,821,000 | -35,000 | 2,439,000 |
| change in cash | -88,000 | 12,000 | 5,000 | -1,000 | -259,000 | 3,224,000 | 4,765,000 | -8,268,000 | 4,863,000 | -1,854,000 | 46,000 | -2,416,000 |
thermo fisher scientific blade vii limited Credit Report and Business Information
Thermo Fisher Scientific Blade Vii Limited Competitor Analysis
Perform a competitor analysis for thermo fisher scientific blade vii limited by selecting its closest rivals, whether from the FINANCIAL AND INSURANCE ACTIVITIES sector, other small companies, companies in WA14 area or any other competitors across 12 key performance metrics.
thermo fisher scientific blade vii limited Ownership
THERMO FISHER SCIENTIFIC BLADE VII LIMITED group structure
Thermo Fisher Scientific Blade Vii Limited has 1 subsidiary company.
Ultimate parent company
THERMO FISHER SCIENTIFIC INC
#0013877
2 parents
THERMO FISHER SCIENTIFIC BLADE VII LIMITED
07579841
1 subsidiary
thermo fisher scientific blade vii limited directors
Thermo Fisher Scientific Blade Vii Limited currently has 4 directors. The longest serving directors include Mr Anthony Smith (Feb 2023) and Mr Syed Ahmed (Feb 2023).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Anthony Smith | United Kingdom | 62 years | Feb 2023 | - | Director |
| Mr Syed Ahmed | United Kingdom | 45 years | Feb 2023 | - | Director |
| Mr Euan Cameron | United Kingdom | 48 years | Feb 2023 | - | Director |
| Ms Alison Starr | United Kingdom | 48 years | Apr 2024 | - | Director |
P&L
December 2023turnover
3.4m
+18%
operating profit
2.8m
+24%
gross margin
35%
+3.19%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
161.6m
+0.23%
total assets
183.4m
+0.2%
cash
29k
-0.75%
net assets
Total assets minus all liabilities
thermo fisher scientific blade vii limited company details
company number
07579841
Type
Private limited with Share Capital
industry
64209 - Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
70100 - Activities of head offices
incorporation date
March 2011
age
14
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2023
previous names
cidron (tbs) ii limited (January 2023)
accountant
-
auditor
ERNST & YOUNG LLP
address
3rd floor 1 ashley road, altrincham, cheshire, WA14 2DT
Bank
HSBC BANK PLC
Legal Advisor
PINSENT MASONS LLP
thermo fisher scientific blade vii limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 3 charges/mortgages relating to thermo fisher scientific blade vii limited. Currently there are 0 open charges and 3 have been satisfied in the past.
thermo fisher scientific blade vii limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for THERMO FISHER SCIENTIFIC BLADE VII LIMITED. This can take several minutes, an email will notify you when this has completed.
thermo fisher scientific blade vii limited Companies House Filings - See Documents
| date | description | view/download |
|---|
